Inovio Pharmaceuticals, INC. (INO) — 8-K Filings

8-K Filings (14)

• INOVIO PHARMACEUTICALS, INC. Files 8-K — Apr 6, 2026 Risk: medium
  On April 2, 2026, INOVIO PHARMACEUTICALS, INC. entered into a material definitive agreement. The filing also includes other events and financial statements/exhi
• 8-K Filing — Apr 2, 2026
• 8-K Filing — Dec 29, 2025
• Inovio Pharmaceuticals Files 8-K with Material Agreement — Nov 12, 2025 Risk: medium
  On November 11, 2025, Inovio Pharmaceuticals, Inc. filed an 8-K report detailing a material definitive agreement. The filing also included other events and fina
• Inovio Pharmaceuticals Files 8-K — Jul 7, 2025 Risk: medium
  On July 2, 2025, Inovio Pharmaceuticals, Inc. entered into a material definitive agreement. The company also reported on other events and filed financial statem
• Inovio Pharmaceuticals Files 8-K on Security Holder Vote — May 22, 2025 Risk: low
  On May 20, 2025, Inovio Pharmaceuticals, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not specify t
• Inovio Pharmaceuticals Files 8-K — Dec 16, 2024 Risk: medium
  On December 12, 2024, Inovio Pharmaceuticals, Inc. entered into a material definitive agreement. The company also reported other events and filed financial stat
• Inovio Pharmaceuticals Files Material Definitive Agreement — Aug 13, 2024 Risk: medium
  On August 13, 2024, Inovio Pharmaceuticals, Inc. filed an 8-K report detailing a material definitive agreement. The filing does not provide specific details on
• Inovio Pharmaceuticals Files 8-K with Financial Updates — Aug 8, 2024 Risk: medium
  On August 8, 2024, Inovio Pharmaceuticals, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and
• Inovio Pharmaceuticals Elects Directors, Ratifies Auditors — May 28, 2024 Risk: low
  On May 21, 2024, Inovio Pharmaceuticals, Inc. filed an 8-K report detailing a shareholder meeting held on May 20, 2024. The meeting included the election of two
• Inovio Pharmaceuticals Files 8-K with Financial Updates — May 13, 2024 Risk: medium
  On May 13, 2024, Inovio Pharmaceuticals, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and e
• Inovio Pharmaceuticals Files 8-K: Material Agreement — Apr 17, 2024 Risk: medium
  On April 15, 2024, Inovio Pharmaceuticals, Inc. entered into a Material Definitive Agreement. The company also reported on other events and filed financial stat
• Inovio Files 8-K on Bylaw Amendments; Governance Changes Ahead — Jan 25, 2024
  Inovio Pharmaceuticals, Inc. filed an 8-K on January 25, 2024, reporting an event from January 24, 2024, related to amendments to its Articles of Incorporation
• Inovio Files 8-K on Shareholder Vote Submission — Jan 12, 2024
  Inovio Pharmaceuticals, Inc. filed an 8-K on January 12, 2024, to report the submission of matters to a vote of security holders. This filing indicates that the

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX